The prognosis of some “multiple classifier”, such as cancers with MMR-deficient/p53-abnormal and POLE-mutated/p53-abnormal double classifier, was reported to be significantly different compared to the prognosis of the single classifier p53-abnormal [20]. The gene discussed is TP53; the disease is cancer.